Peter A. Blenkinsop advises clients on data privacy, research compliance, and e-health. He co-chairs the firm’s Information Privacy, Security & Governance practice. Peter represents clients in the life sciences, health, nutrition, and technology sectors, among others.
Peter’s focus on data privacy and security law began well over a decade ago in the run up to implementation of the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”). Since then, his practice has expanded well beyond health information privacy to data privacy and security generally. He advises companies on compliance issues raised by US federal and state privacy laws such as the Children’s Online Privacy Protection Act (“COPPA”), the CAN-SPAM Act, the Telephone Consumer Protection Act, and the Junk Fax Prevention Act. In this role, he assists clients in identifying privacy and security risks and developing information governance programs.
Peter also advises companies on compliance with international data transfer issues under the EU Data Protection Directive and other foreign privacy laws. He has assisted a number of multinationals in the development of their global privacy compliance programs. He regularly monitors and reports to clients on developments in data privacy laws worldwide.
As a member of the life sciences and pharmaceutical practices, Peter assists health industry clients with legal issues related to medical research, including clinical trials compliance, collection and use of human biological samples, and international research requirements. He advises companies on compliance with the Food and Drug Administration (FDA) and Department of Health and Human Services (HHS) human subject protection regulations, as well as guidelines for medical research issued by the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), World Health Organization, and World Medical Association.
Peter also advises companies on compliance with FDA and Federal Trade Commission (FTC) requirements related to the marketing of drugs, devices, and consumer healthcare products. This includes advising companies on development of mobile health applications, health websites, and health and fitness wearables.
Peter helps manage the International Pharmaceutical Privacy Consortium and Medical Device Privacy Consortium. In these roles, he has been instrumental in crafting industry comments on legislative and regulatory proposals related to data privacy in the US and European Union.Peter has worked with a leading nutrition company, a large auto manufacturer and dozens of the top pharmaceutical and medical device companies on privacy and security projects, analyzing specific programs and activities, providing advice on compliance with relevant laws, conducting large-scale privacy gap assessments to compare practices to legal requirements and best practices, and assisting companies in development of data protection programs. He regularly advises on cross-border data transfer questions and matters necessitating the collection of personal data from outside the US (e.g., international legal discovery).
Peter works with clients in the development of privacy policies and procedures, including overarching privacy policies, and policies and procedures for sales and marketing, research, and human resources. He has also assisted in the development of IT security policies and security incident response plans and procedures. He often provides training for clients’ personnel and works with them to implement data privacy and security programs that fit their operational structures. In collaboration with local firms, Peter assists in global projects aimed at registering data processing activities and databases with data protection authorities.
- District of Columbia
- Georgetown University Law Center, J.D., 2006, magna cum laude
- Yale University, B.A., 1999, cum laude
- District of Columbia Bar Association
- International Association of Privacy Professionals